Sugasawa K, Ng JM, Masutani C, Iwai S, van der Spek PJ, Eker AP, Hanaoka F, Bootsma D, Hoeijmakers JH. Xeroderma pigmentosum group C protein complex is the initiator of global genome nucleotide excision repair. Mol. Cell. 1998, 2 (2): 223–32. PMID 9734359. doi:10.1016/s1097-2765(00)80132-x.
Kastan MB. DNA damage responses: mechanisms and roles in human disease: 2007 G.H.A. Clowes Memorial Award Lecture. Mol. Cancer Res. 2008, 6 (4): 517–24. PMID 18403632. doi:10.1158/1541-7786.MCR-08-0020.
Yang J, Xu Z, Li J, Zhang R, Zhang G, Ji H, Song B, Chen Z. XPC epigenetic silence coupled with p53 alteration has a significant impact on bladder cancer outcome. J. Urol. 2010, 184 (1): 336–43. PMID 20488473. doi:10.1016/j.juro.2010.03.044.
Yeh KT, Wu YH, Lee MC, Wang L, Li CT, Chen CY, Lee H. XPC mRNA level may predict relapse in never-smokers with non-small cell lung cancers. Ann. Surg. Oncol. 2012, 19 (3): 734–42. PMID 21861227. S2CID 19154489. doi:10.1245/s10434-011-1992-9.
Araki M, Masutani C, Takemura M, Uchida A, Sugasawa K, Kondoh J, Ohkuma Y, Hanaoka F. Centrosome protein centrin 2/caltractin 1 is part of the xeroderma pigmentosum group C complex that initiates global genome nucleotide excision repair. J. Biol. Chem. June 2001, 276 (22): 18665–72. PMID 11279143. doi:10.1074/jbc.M100855200.
Yokoi M, Masutani C, Maekawa T, Sugasawa K, Ohkuma Y, Hanaoka F. The xeroderma pigmentosum group C protein complex XPC-HR23B plays an important role in the recruitment of transcription factor IIH to damaged DNA. J. Biol. Chem. March 2000, 275 (13): 9870–5. PMID 10734143. doi:10.1074/jbc.275.13.9870.
Sugasawa K, Ng JM, Masutani C, Iwai S, van der Spek PJ, Eker AP, Hanaoka F, Bootsma D, Hoeijmakers JH. Xeroderma pigmentosum group C protein complex is the initiator of global genome nucleotide excision repair. Mol. Cell. 1998, 2 (2): 223–32. PMID 9734359. doi:10.1016/s1097-2765(00)80132-x.
Kastan MB. DNA damage responses: mechanisms and roles in human disease: 2007 G.H.A. Clowes Memorial Award Lecture. Mol. Cancer Res. 2008, 6 (4): 517–24. PMID 18403632. doi:10.1158/1541-7786.MCR-08-0020.
Yang J, Xu Z, Li J, Zhang R, Zhang G, Ji H, Song B, Chen Z. XPC epigenetic silence coupled with p53 alteration has a significant impact on bladder cancer outcome. J. Urol. 2010, 184 (1): 336–43. PMID 20488473. doi:10.1016/j.juro.2010.03.044.
Yeh KT, Wu YH, Lee MC, Wang L, Li CT, Chen CY, Lee H. XPC mRNA level may predict relapse in never-smokers with non-small cell lung cancers. Ann. Surg. Oncol. 2012, 19 (3): 734–42. PMID 21861227. S2CID 19154489. doi:10.1245/s10434-011-1992-9.
Araki M, Masutani C, Takemura M, Uchida A, Sugasawa K, Kondoh J, Ohkuma Y, Hanaoka F. Centrosome protein centrin 2/caltractin 1 is part of the xeroderma pigmentosum group C complex that initiates global genome nucleotide excision repair. J. Biol. Chem. June 2001, 276 (22): 18665–72. PMID 11279143. doi:10.1074/jbc.M100855200.
Yokoi M, Masutani C, Maekawa T, Sugasawa K, Ohkuma Y, Hanaoka F. The xeroderma pigmentosum group C protein complex XPC-HR23B plays an important role in the recruitment of transcription factor IIH to damaged DNA. J. Biol. Chem. March 2000, 275 (13): 9870–5. PMID 10734143. doi:10.1074/jbc.275.13.9870.
Yeh KT, Wu YH, Lee MC, Wang L, Li CT, Chen CY, Lee H. XPC mRNA level may predict relapse in never-smokers with non-small cell lung cancers. Ann. Surg. Oncol. 2012, 19 (3): 734–42. PMID 21861227. S2CID 19154489. doi:10.1245/s10434-011-1992-9.